Evidence review · standard
semax statins
Regeneration vs degeneration — where this fits
statins represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether semax mechanisms address underlying repair deficits.
What is known
Studied for BDNF and neural support — building connections, not sedating symptoms.
Target condition: statins. Body system: Lipid management; debated cognitive/muscle side effects in subset..
Logic chain
- semax studied for bdnf and neural support — building connections, not sedating symptoms..
- statins involves lipid management; debated cognitive/muscle side effects in subset. dysfunction.
- If semax reaches the affected tissue, it may shift the repair/breakdown balance.
- This chain is tested in animal or lab models only.
Parent peptide claims relevant here
- In rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression.
- In a study of 110 patients after ischemic stroke, Semax increased plasma BDNF levels.
- Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.
- 2025 study showing Semax improves cognitive functions in transgenic Alzheimer's disease mouse model.
- 2025 study on Semax for spinal cord injury recovery in mice.
Evidence tier
Preclinical — animal and in vitro studies only. No published human trials for this specific combination.
What we do not know
- Whether semax reaches statins tissue at functional concentrations
- Optimal dosing, route, and duration for this target
- Interaction with standard-of-care treatments for statins
- Long-term safety profile in this population
Safety note
All peptide use for statins is research-context only. Not medical advice. Consult a physician before any experimental compound.
Key evidence
system
Combinatorial mapping (transparent): semax vs statins — regen=0.59, degen=0.45, Δ=0.14. Method: layer_relevance(0.60) × evidence_factor(0.85); catalog.degen_score for Statins.
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
Machine verification:
/api/articles/semax-statins/contributionsAsk this article · 3 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.
What does the ledger say about this (system tier): "Combinatorial mapping (transparent): semax vs statins — regen=0.59, degen=0.45, Δ=0.14. Method: layer_relevance(0.60) × evidence_factor(0.85…"?
ask semax-statins claim c_map_semax-statins · paste includes §SELF
What can you answer from your catalogue about semax statins — and what remains open or unverified?
ask semax-statins gaps · paste includes §SELF
What are the strongest objections or counter-evidence on record against semax statins?
ask semax-statins objections · paste includes §SELF